The main purpose of this combined core is to provide a comprehensive service using state-of-the-art molecular and genetic methods to generate a variety of sophisticated knock-in, knock-out and transgenic mice for DRC investigators in their type 1 and type 2 diabetes research. We have successfully generated many lines of knock-in, knock-out and transgenic mice related to diabetes studies. It is noteworthy three ofthe highlights among all the animals generated during the previous funding cycle. Firstly, humanized mice, which carry 5 human genes by sequential re-targeting the same ES cells. The engraftment of human fetal liver-derived CD34+ hematopoietic stem cells can reach nearly 100% and last up to 9 months in this humanized mouse. Secondly, lines of innate immunity deficient NOD mice for the studies of type 1 diabetes, especially in association with exogenous and endogenous environmental factors. Using MyD88 deficient NOD mice generated by the core, DRC investigators demonstrated the importance of commensal flora in type 1 diabetes development and gut flora is an environmental modifier that influence diabetes onset Thirdly, lines of inflammsome deficient B6 mice for the studies of metabolic syndrome and type 2 diabetes. DRC investigators found that inflammasomes NLRP3 and NLRP6 negatively regulate NAFLD progression and obesity via modulation ofthe gut flora. This combined core consists of three subcores - Molecular, Gene targeting and Mouse breeding (MGM) components. Each subcore has its distinct function while all is interconnected. We will continue to provide our outstanding service for Yale DRC community. Moleculai: subcore will increase the use of improved high efficiency BAC mutagenesis to facilitate the generation of customized constructs for both type 1 and type 2 diabetes studies. Together with Molecular subcore. Gene targeting subcore will extend the humanized mouse model systems to include diabetes-related genes in order to evaluate preclinical testing of new therapies and/or vaccines, by our DRC investigators, for treatment and prevention type 1 diabetes. Mouse breeding subcore will backcross the improved humanized mouse lines to NOD background and several lines of infammasome deficient mice to pure NOD background forthe studies of type 1 diabetes.

Public Health Relevance

The creation of novel mouse models through genetic engineering provides new insights into the mechanisms responsible for the development of human diabetes and a means of testing novel therapies for the disease.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-S)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Yale University
New Haven
United States
Zip Code
Belfort-DeAguiar, Renata; Seo, Dongju; Lacadie, Cheryl et al. (2018) Humans with obesity have disordered brain responses to food images during physiological hyperglycemia. Am J Physiol Endocrinol Metab 314:E522-E529
Szczepanik, Marian; Majewska-Szczepanik, Monika; Wong, Florence S et al. (2018) Regulation of contact sensitivity in non-obese diabetic (NOD) mice by innate immunity. Contact Dermatitis 79:197-207
Yu, Hua; Paiva, Ricardo; Flavell, Richard A (2018) Harnessing the power of regulatory T-cells to control autoimmune diabetes: overview and perspective. Immunology 153:161-170
Samuel, Varman T; Shulman, Gerald I (2018) Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases. Cell Metab 27:22-41
Abulizi, Abudukadier; Camporez, João-Paulo; Zhang, Dongyan et al. (2018) Ectopic lipid deposition mediates insulin resistance in adipose specific 11?-Hydroxysteroid dehydrogenase type 1 transgenic mice. Metabolism :
Rash, Brian G; Micali, Nicola; Huttner, Anita J et al. (2018) Metabolic regulation and glucose sensitivity of cortical radial glial cells. Proc Natl Acad Sci U S A 115:10142-10147
Kumar, Nikit; Leonzino, Marianna; Hancock-Cerutti, William et al. (2018) VPS13A and VPS13C are lipid transport proteins differentially localized at ER contact sites. J Cell Biol 217:3625-3639
Flannery, Clare A; Choe, Gina H; Cooke, Katherine M et al. (2018) Insulin Regulates Glycogen Synthesis in Human Endometrial Glands Through Increased GYS2. J Clin Endocrinol Metab 103:2843-2850
Benedetti, Lorena; Barentine, Andrew E S; Messa, Mirko et al. (2018) Light-activated protein interaction with high spatial subcellular confinement. Proc Natl Acad Sci U S A 115:E2238-E2245
Perry, Rachel J; Wang, Yongliang; Cline, Gary W et al. (2018) Leptin Mediates a Glucose-Fatty Acid Cycle to Maintain Glucose Homeostasis in Starvation. Cell 172:234-248.e17

Showing the most recent 10 out of 620 publications